Benitec Biopharma Inc.BNTCNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-12.68%
Near historical average
Percentile
P44
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-13.20%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -12.68% |
| Q3 2025 | 60.71% |
| Q2 2025 | -176.36% |
| Q1 2025 | 59.94% |
| Q4 2024 | -67.97% |
| Q3 2024 | -39.27% |
| Q2 2024 | 47.21% |
| Q1 2024 | -16.95% |
| Q4 2023 | -16.53% |
| Q3 2023 | -19.31% |
| Q2 2023 | 4.78% |
| Q1 2023 | 28.71% |
| Q4 2022 | -39.72% |
| Q3 2022 | 14.25% |
| Q2 2022 | -37.85% |
| Q1 2022 | -2.33% |
| Q4 2021 | 21.83% |
| Q3 2021 | 17.04% |
| Q2 2021 | -159.28% |
| Q1 2021 | 40.20% |
| Q4 2020 | -40.93% |
| Q3 2020 | 24.96% |
| Q2 2020 | -391.18% |
| Q1 2020 | 79.14% |
| Q4 2019 | -167.66% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 100.00% |
| Q4 2018 | -130.27% |
| Q3 2018 | 401.15% |
| Q2 2018 | 5.83% |
| Q1 2018 | 51.51% |
| Q4 2017 | -64.19% |
| Q3 2017 | -18.24% |
| Q2 2017 | -203.43% |
| Q1 2017 | 158.31% |
| Q4 2016 | 20.48% |
| Q3 2016 | -161.70% |
| Q2 2016 | 55.86% |
| Q1 2016 | 45.81% |